Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 21

Results For "COPE"

209 News Found

Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22
Healthcare | August 16, 2021

Fortis Healthcare PAT at Rs 263.55 cr in Q1FY22

It has initiated investments for advanced medical equipment such as Cath Labs, neuro microscopes, bone marrow transplant units at select facilities


Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation
Healthcare | August 16, 2021

Nanavati Max is the first in Mumbai to receive NABH-MIS accreditation

National Accreditation Board for Hospitals & Healthcare Providers (NABH) is a constituent board of the Quality Council of India, set up to establish and operate accreditation programmes for healthcare organisations


Sun Pharma Speciality business looks encouraging: HDFC Securities
News | August 13, 2021

Sun Pharma Speciality business looks encouraging: HDFC Securities

Winlevi, the recently added anti-acne product with a new mechanism of action and broad-based use (vs Absorica), will further boost the derma portfolio and Speciality business growth


Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026
Supply Chain | August 11, 2021

Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026

A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report


Sun Pharma launches 'Sunkalp' on National Doctors' Day
News | July 01, 2021

Sun Pharma launches 'Sunkalp' on National Doctors' Day

Sun Pharma has committed Rs. 100 crores towards these initiatives


Pfizer registers Q4FY21net profit at Rs 100 Cr
News | May 26, 2021

Pfizer registers Q4FY21net profit at Rs 100 Cr

Revenue from operations for the year ended March 31, 2021 is ?2,239 crore


Biosimilars performance below expectations for Biocon : ICICI Direct
Biotech | May 03, 2021

Biosimilars performance below expectations for Biocon : ICICI Direct

The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.


Merck publishes sustainability report for 2020
News | April 13, 2021

Merck publishes sustainability report for 2020

The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.


Merck FY20 sales up 8.6% euro 17.5 bn
News | March 04, 2021

Merck FY20 sales up 8.6% euro 17.5 bn

Merck forecasts organic growth of EBITDA pre in a high single-digit to low teens percentage range in 2021.